Early, intensive treatment of RA offers long-term benefits, may normalise mortality rates

The results of a 23-year, follow-up study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest early, intensive treatment of rheumatoid arthritis has long-term benefits including the normalisation of mortality to levels consistent with the general population. “We know that the adverse effects of rheumatoid arthritis on the body only become truly apparent after more than a […]

Continue reading »

Addressing parents’ HPV vaccine hesitancy ups vaccination rates

(HealthDay)—Providers engaging parents hesitant about human papillomavirus (HPV) vaccination and addressing their concerns can lead to same-day vaccinations, according to a study published online May 15 in Pediatrics. Laura A. Shay, Ph.D., from the University of Texas in San Antonio, and colleagues audio-recorded 43 visits with unvaccinated adolescents at six pediatric clinics in which parents were undecided about HPV vaccination. […]

Continue reading »

Type 2 diabetes slowly rising in Auckland kids – Pacific and Māori have highest rates

New research shows increasing numbers of children and teens under-15 in Auckland are developing type 2 diabetes, and that rates among Pacific and Māori children are up to 18 times higher than for European children. The findings are based on 21 years of patient records from Starship Paediatric Diabetes Service. Says study lead Dr. Craig Jefferies: “People still don’t think […]

Continue reading »

HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly

HCV-related liver transplantation rates in Europe have declined dramatically since the availability of direct-acting antiviral (DAA) drugs and survival rates after transplantation have reached an all-time high. A study presented today at The International Liver Congress 2018 in Paris, France, has found that the percentage of liver transplants performed as a result of hepatitis C virus (HCV) infection has more […]

Continue reading »

Punjab, India: Mass treatment of a population with chronic hepatitis C infection produces high rates of cure

A large-scale study evaluating the feasibility of decentralized care and the provision of free direct-acting antiviral agents (DAAs) has reported high rates of cure among a population of almost 20,000 individuals completing treatment for hepatitis C virus (HCV) infection. The study conducted in Punjab, India, which was reported today at The International Liver Congress 2018 in Paris, France, validated the […]

Continue reading »
1 2